Clinical Trials Directory

Trials / Terminated

TerminatedNCT04155008

Nutrition and Pharmacological Algorithm for Oncology Patients Study

Assessing Quality of Life and the Feasibility of a Nutrition and Pharmacological Algorithm for Oncology Patients With Anorexia

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Montefiore Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatment and improve the quality of life of patients by implementing an algorithm utilizing nutrition intervention and appetite stimulants.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasoneIf the patient's prognosis is extremely poor (less than 12 weeks expected survival, based on discussion with the patient's treating physicians) and there is no additional disease modifying therapy planned, the patient will be prescribed 4mg dexamethasone (which is FDA approved), once daily, to be taken orally in the morning.
DRUGDronabinolIf the patient has a history of marijuana use or has tried it in the past and had a positive experience with it, then the patient will be prescribed dronabinol (which is FDA approved) 2.5mg, twice daily before meals.
DRUGMirtazapineIf the patient does not have any history of marijuana use, mirtazapine will be prescribed. If the patient is under the age of 70, then the patient would be prescribed 15mg of mirtazapine (which is FDA approved), once daily, to be taken orally at bedtime. For geriatric population (if the patient is over the age of 70), then the patient would be prescribed 7.5mg of mirtazapine, once daily to be taken orally at bedtime.
BEHAVIORALNutrition InterventionNutrition intervention will be in accordance with the Academy of Nutrition and Dietetics guidelines. The intervention will involve "purposefully planned action(s) designed with the intent of changing a nutrition-related behavior, risk factor, environmental condition, or aspect of health status

Timeline

Start date
2021-03-01
Primary completion
2021-04-05
Completion
2021-04-05
First posted
2019-11-07
Last updated
2022-11-16
Results posted
2022-11-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04155008. Inclusion in this directory is not an endorsement.